Handelsavisen
prelaunch
Companies Healthcare VVTM.V
VV
VVTM.V TSX Venture Medical Equipment, Supplies & Distribution

Vvtm.V

$0,30
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
14,9 %
Net margin
Debt / equity
-0,72
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

VVTM.V operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Business. VVTM.V operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
14,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning VVTM.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to VVTM.V. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    VVTM.V operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure is highly leveraged, with total liabilities of $794,158 million and total equity of -$775,382 million, resulting in a negative debt-to-equity ratio of -0.72. Liquidity is critically low, as evidenced by a current ratio of 0.02, indicating the company is unable to meet its short-term obligations with its current assets. The negative operating cash flow of -$72,991 million and free cash flow of -$115,326 million further underscore the company's liquidity challenges.

    Profitability is severely underperforming, with a net loss of $115,326 million and an operating loss of the same amount. The return on assets is -6.14%, significantly below the industry median, and the return on equity is 14.87%, which is misleading due to the negative equity base. These metrics indicate the company is not generating returns from its assets or equity and is operating at a loss.

    The company's revenue concentration is not disclosed in the available data, but the negative equity and high debt levels suggest a lack of diversification or resilience in its business model. There is no information on geographic exposure or segment performance, which limits the ability to assess the company's risk profile in different markets or product lines.

    The company's growth trajectory is negative, with no outlook data provided for the current or next fiscal year. The historical financial performance, including a net loss and negative cash flows, indicates a declining trend in operations. Without a clear path to profitability or liquidity improvement, the company's future growth is uncertain.

    The company faces significant liquidity and solvency risks, as highlighted by the risk assessment, which identifies a medium liquidity risk and a key flag of negative net cash after subtracting total debt. The dilution risk is currently low, but the company's negative equity and high debt levels could lead to future dilution if it needs to raise additional capital. The valuation adjustments applied in the custom valuations do not provide any mitigating factors for these risks.

    There are no recent events or filings disclosed in the available data to provide insight into the company's current operations or strategic direction. The lack of recent information makes it difficult to assess any changes in the company's business model or financial strategy.

    Key takeaways
    • The company is operating at a significant loss with negative operating and net income.
    • Liquidity is critically low, with a current ratio of 0.02 and negative free cash flow.
    • The company's capital structure is highly leveraged, with total liabilities exceeding total assets.
    • Profitability metrics are severely underperforming, with a negative return on assets and a misleadingly high return on equity due to negative equity.
    • There is no recent information on the company's strategic direction or operational changes.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,30
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    -$775.4k
    Net cash
    -$556.3k
    Current ratio
    0.0
    Debt / equity
    -0.7
    ROA
    -6.1%
    ROE
    14.9%
    Cash conversion
    63.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE14,9 %Above P75
    D/E-0,72Best in class
    Cash Conv0,63Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • VVTM.V Market data — financials · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    VVTM.VCanonical
    TSX Venture · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage